Use of transesophageal echocardiography to select patients for cardioversion
Claire Braybrook
This article has no abstract so we have provided the first paragraph of the full text.
Cardioversion can improve heart function, reduce the risk of embolism and relieve symptoms in patients with atrial fibrillation. Despite anticoagulation therapy, thromboembolic complications can still occur if thrombi form and migrate either at the start of cardioversion or after cardioversion.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
